Pharma Commercial Mock
IQVIA
Connected Intelligence™
National Prescription Audit
Source: NPA Weekly · Refresh: 2026-05-29·Marten Veskimae
Brand-level trends · ZENVARA

Weekly NPA dashboard · national

TRx (week)
2,037 11.9%
vs WK28, 2026-05-29
NRx (week)
586 8.1%
vs prior week
NBRx (week)
120 6.2%
new-to-brand
Cumulative TRx
24,445
12-week window
📈TRx — plan vs actual
09161,8332,74903-1303-2704-1004-2405-0805-22
Plan Actual
📊NRx ⨉ NBRx trend
03-1303-2704-1004-2405-0805-22
NRx NBRx
🍩Channel mix
RETAIL32%MAIL60%LTC8%
🗺️Geography — variance vs plan
WestMidwestNortheastSoutheast
Variance vs plan — darker = worse. Northeast highlighted as primary deviation region.
Weekly detail · 12 weeks
Week EndingTRxNRxNBRxPlan TRxVar %Cum TRx
2026-03-132,1506331582,479-13.3%2,150
2026-03-202,0576331572,483-17.2%4,207
2026-03-272,0336051492,487-18.3%6,240
2026-04-032,2266931642,490-10.6%8,466
2026-04-101,9615841402,492-21.3%10,427
2026-04-171,9946051442,494-20.0%12,421
2026-04-242,1876311402,495-12.3%14,608
2026-05-011,8745401212,496-24.9%16,482
2026-05-082,1256241442,497-14.9%18,607
2026-05-151,9805921222,498-20.7%20,587
2026-05-221,8215421132,498-27.1%22,408
2026-05-292,0375861202,499-18.5%24,445
© 2026 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union and various other countries. NPA™, Xponent™ and Connected Intelligence™ are trademarks of IQVIA Inc. This view is a demo mock and is not affiliated with IQVIA.